These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38381402)

  • 1. Partial Reprogramming as a Method for Regenerating Neural Tissues in Aged Organisms.
    Sichani AS; Khoddam S; Shakeri S; Tavakkoli Z; Jafroodi AR; Dabbaghipour R; Sisakht M; Fallahi J
    Cell Reprogram; 2024 Feb; 26(1):10-23. PubMed ID: 38381402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Transient and Partial Cell Reprogramming to Pluripotency as a Therapeutic Tool for Neurodegenerative Diseases.
    Tamanini S; Comi GP; Corti S
    Mol Neurobiol; 2018 Aug; 55(8):6850-6862. PubMed ID: 29353456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular signature defining exercise adaptation with ageing and in vivo partial reprogramming in skeletal muscle.
    Jones RG; Dimet-Wiley A; Haghani A; da Silva FM; Brightwell CR; Lim S; Khadgi S; Wen Y; Dungan CM; Brooke RT; Greene NP; Peterson CA; McCarthy JJ; Horvath S; Watowich SJ; Fry CS; Murach KA
    J Physiol; 2023 Feb; 601(4):763-782. PubMed ID: 36533424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejuvenation by Partial Reprogramming of the Epigenome.
    Mendelsohn AR; Larrick JW; Lei JL
    Rejuvenation Res; 2017 Apr; 20(2):146-150. PubMed ID: 28314379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
    Ocampo A; Reddy P; Martinez-Redondo P; Platero-Luengo A; Hatanaka F; Hishida T; Li M; Lam D; Kurita M; Beyret E; Araoka T; Vazquez-Ferrer E; Donoso D; Roman JL; Xu J; Rodriguez Esteban C; Nuñez G; Nuñez Delicado E; Campistol JM; Guillen I; Guillen P; Izpisua Belmonte JC
    Cell; 2016 Dec; 167(7):1719-1733.e12. PubMed ID: 27984723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice.
    Browder KC; Reddy P; Yamamoto M; Haghani A; Guillen IG; Sahu S; Wang C; Luque Y; Prieto J; Shi L; Shojima K; Hishida T; Lai Z; Li Q; Choudhury FK; Wong WR; Liang Y; Sangaraju D; Sandoval W; Esteban CR; Delicado EN; Garcia PG; Pawlak M; Vander Heiden JA; Horvath S; Jasper H; Izpisua Belmonte JC
    Nat Aging; 2022 Mar; 2(3):243-253. PubMed ID: 37118377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming neurons for regeneration: The fountain of youth.
    Yang SG; Wang XW; Qian C; Zhou FQ
    Prog Neurobiol; 2022 Jul; 214():102284. PubMed ID: 35533809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
    van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
    Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Age Reversal by Cell-Extrinsic and Cell-Intrinsic Means.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2019 Oct; 22(5):439-446. PubMed ID: 31578938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
    Miyamoto T; Furusawa C; Kaneko K
    PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming.
    Chondronasiou D; Gill D; Mosteiro L; Urdinguio RG; Berenguer-Llergo A; Aguilera M; Durand S; Aprahamian F; Nirmalathasan N; Abad M; Martin-Herranz DE; Stephan-Otto Attolini C; Prats N; Kroemer G; Fraga MF; Reik W; Serrano M
    Aging Cell; 2022 Mar; 21(3):e13578. PubMed ID: 35235716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial reprogramming as a therapeutic approach for heart disease: A state-of-the-art review.
    Talkhabi M
    J Cell Biochem; 2019 Sep; 120(9):14247-14261. PubMed ID: 31081174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape.
    Papp B; Plath K
    Cell Res; 2011 Mar; 21(3):486-501. PubMed ID: 21321600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic rejuvenation by partial reprogramming.
    Puri D; Wagner W
    Bioessays; 2023 Apr; 45(4):e2200208. PubMed ID: 36871150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejuvenation by cell reprogramming: a new horizon in gerontology.
    Goya RG; Lehmann M; Chiavellini P; Canatelli-Mallat M; Hereñú CB; Brown OA
    Stem Cell Res Ther; 2018 Dec; 9(1):349. PubMed ID: 30558644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of small molecules on cell reprogramming.
    Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
    Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity.
    Olova N; Simpson DJ; Marioni RE; Chandra T
    Aging Cell; 2019 Feb; 18(1):e12877. PubMed ID: 30450724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation.
    Lehmann M; Canatelli-Mallat M; Chiavellini P; Cónsole GM; Gallardo MD; Goya RG
    Curr Gene Ther; 2019; 19(4):248-254. PubMed ID: 31475896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven Modules.
    Zviran A; Mor N; Rais Y; Gingold H; Peles S; Chomsky E; Viukov S; Buenrostro JD; Scognamiglio R; Weinberger L; Manor YS; Krupalnik V; Zerbib M; Hezroni H; Jaitin DA; Larastiaso D; Gilad S; Benjamin S; Gafni O; Mousa A; Ayyash M; Sheban D; Bayerl J; Aguilera-Castrejon A; Massarwa R; Maza I; Hanna S; Stelzer Y; Ulitsky I; Greenleaf WJ; Tanay A; Trumpp A; Amit I; Pilpel Y; Novershtern N; Hanna JH
    Cell Stem Cell; 2019 Feb; 24(2):328-341.e9. PubMed ID: 30554962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.